[HTML][HTML] Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response
S Gandhi, HL Sweeney, CC Hart, R Han, CGR Perry - Cells, 2024 - mdpi.com
Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disease caused by
mutations to the dystrophin gene, resulting in deficiency of dystrophin protein, loss of …
mutations to the dystrophin gene, resulting in deficiency of dystrophin protein, loss of …
Right ventricular preload and afterload challenge induces contractile dysfunction and arrhythmia in isolated hearts of dystrophin‐deficient male mice
A Behrmann, J Cayton, MR Hayden… - Physiological …, 2024 - Wiley Online Library
Duchenne muscular dystrophy (DMD) is an X‐linked recessive myopathy due to mutations
in the dystrophin gene. Diaphragmatic weakness in DMD causes hypoventilation and …
in the dystrophin gene. Diaphragmatic weakness in DMD causes hypoventilation and …
Mitochondria in Duchenne Muscular Dystrophy-induced Cardiomyopathy: A Prospective Therapeutic Target to Improve Treatment Response
S Gandhi, HL Sweeney, CC Hart, R Han, CGR Perry - 2024 - preprints.org
Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disease caused by
mutations to the dystrophin gene-resulting in deficiency of dystrophin protein, loss of …
mutations to the dystrophin gene-resulting in deficiency of dystrophin protein, loss of …